Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting

FEMS Immunology and Medical Microbiology

Volumn 35, Issue 1, 2003, Pages 59-65

  Zanotto, Carlo ^a   Elli, Veronica ^a   Basavecchia, Valeria ^a   Brivio, Alessandro ^a   Paganini, Manuela ^a   Pinna, Debora ^b   Vicenzi, Elisa ^b   De Giuli Morghen, Carlo ^a   Radaelli, Antonia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Fowlpox virus; Prime boost vaccination; Recombinant vaccine; Virus like particle

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRD DISEASE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; NONHUMAN; PATHOGENICITY; PRIMATE; PRIORITY JOURNAL; RABBIT; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS PARTICLE;

AIDS VACCINES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FOWLPOX VIRUS; GENETIC VECTORS; HIV; HIV INFECTIONS; HUMANS; IMMUNIZATION, SECONDARY; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; PLASMIDS; RABBITS; RECOMBINATION, GENETIC; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, DNA; VIRION;

EID: 0037458526     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00455-8     Document Type: Article

References (22)

1. Leno, M., Buge, S.L., Patterson, J. and Robert-Guroff, M. (2000) Development of prophylactic vaccines against HIV. In: Pharmacology of HIV Infection and AIDS (Fuchs, D. and Aruoma, O.I., Eds.), pp. 71-104.
2. Nabel G.J. Challenges and opportunities for development of an AIDS vaccine. Nature. 410:2001;1002-1007.
3. Bojak A., Deml L., Wagner R. The past, present and future of HIV-vaccine development: a critical view. Drug Discov. Today. 7:2002;36-46.
4. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:1999;857-860.
5. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:2000;207-210.
6. Heeney J., Åkerblom L., Barnett S., Borges W., Davis D., Fuller D., Koopman G., Lehner T., Mooij P., Morein B., De Giuli Morghen C., Rosenwirth B., Verschoor E., Wagner R., Wolf H. HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: complied preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunol. Lett. 66:1999;189-195.
7. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., Rizvi T.A., Lu S., Hu S., Mazzara G.P., Panicali D.L., Herndon J.G., Glickman R., Candido M.A., Lydy S.L., Wyand M.S., McLure H.M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat. Med. 5:1999;526-534.
8. Heeney J.L., Teeuwsen V.J.P., van Gils M., Bogers W.M.J., De Giuli Morghen C., Radaelli A., Barnett S., Morein B., Åkerblom L., Wang Y., Lehner T., Davis D. β-Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc. Natl. Acad. Sci. USA. 95:1998;10803-10808.
9. Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., Martin M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infection of macaques monkeys. Nat. Med. 5:1999;204-210.
10. Aiyar A., Leis J. Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. BioTechniques. 14:1993;366-369.
11. Radaelli A., De Giuli Morghen C. Expression of HIV-1 envelope gene by recombinant avipox viruses. Vaccine. 12:1994;1101-1109.
12. Yuen L., Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA. 84:1987;6417-6421.
13. SF2 env gene. Vaccine. 12:1994;1110-1117.
14. Gervaix A., West D., Leoni L.M., Richman D.D., Wong-Staal F., Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA. 94:1997;4653-4658.
15. + lymphocyte depletion in rhesus monkeys. J. Virol. 71:1997;4218-4225.
16. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Rac P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., Letvin N.L. An env gene derived from a primary Human Immunodeficiency Virus type 1 isolate confers high in vivo replicative capacity to a chimeric Simian/Human Immunodeficiency Virus in Rhesus monkeys. J. Virol. 70:1996;3198-3206.
17. Richmond J.F., Mustafa F., Lu S., Santoro J.C., Weng J., O'Connell M., Fenyo E.M., Hurwitz J.L., Montefiori D.C., Robinson H.L. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Virology. 230:1997;265-274.
18. Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a Human Immunodeficiency Virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:1998;10180-10188.
19. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., Montefiori D.C., Xu Y., Herndon J.G., Wyatt L.S., Candido M.A., Kozyr N.L., Earl P.L., Smith J.M., Ma H.-L., Grimm B.D., Hulsey M.L., Miller J., McClure H.M., McNicholl J.M., Moss B., Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science. 292:2001;69-74.
20. Wagner R., Teeuwsen V.J.P., Demi L., Nokta F., Haaksma A.G.M., Jhagjhoorsingh S.S., Niphuis H., Wolf H., Heeney J.L. Cytotoxic T cells and neutralizing antibodies induced in Rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology. 245:1998;65-74.
21. Desrosier, R. (2001) Avoidance of antibody recognition by SIV- and HIV-encoded envelope proteins. Abstract from the 'AIDS Conference on Retroviruses and Opportunistic Infections', Chicago, IL.
22. Radaelli A., Gimelli M., Zanotto C., De Giuli Morghen C. Correlation between the immune response elicited in rabbits by env-recombinant avipox vaccines and the inhibition of HIV-1 specific functions. FEMS Immunol. Med. Microbiol. 27:2000;211-218.